Radiographic response to neoadjuvant therapy and its impact on scope of surgery and prognosis in stage IIB/III soft tissue sarcomas

por Chen, Yong, Yang, Yun, Wang, ChunMeng, Shi, YingQiang
Publicado 2013

Surgical resection margin for T3–T4 primary acral melanoma: a multicenter retrospective cohort study

por Sun, Wei, Xu, Yu, Qu, XingLong, Jin, YongJia, Wang, ChunMeng, Yan, WangJun, Chen, Yong
Publicado 2023

Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials

por Zhang, Wen-ying, Liu, Yang, Wang, Yao, Wang, Chun-meng, Yang, Qing-ming, Zhu, Hong-li, Han, Wei-dong
Publicado 2017

Metabolism of Reactive Oxygen Species in Osteosarcoma and Potential Treatment Applications

por Sun, Wei, Wang, Bing, Qu, Xing-Long, Zheng, Bi-Qiang, Huang, Wen-Ding, Sun, Zheng-Wang, Wang, Chun-Meng, Chen, Yong
Publicado 2019

A real‐world study of adjuvant anti‐PD ‐1 immunotherapy on stage III melanoma with BRAF, NRAS, and KIT mutations

por Sun, Wei, Xu, Yu, Yan, WangJun, Wang, ChunMeng, Hu, Tu, Luo, ZhiGuo, Zhang, XiaoWei, Liu, Xin, Chen, Yong
Publicado 2023

Treatment of CD20-directed Chimeric Antigen Receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report

por Zhang, Wen-ying, Wang, Yao, Guo, Ye-lei, Dai, Han-ren, Yang, Qing-ming, Zhang, Ya-jing, Zhang, Yan, Chen, Mei-xia, Wang, Chun-meng, Feng, Kai-chao, Li, Su-xia, Liu, Yang, Shi, Feng-xia, Luo, Can, Han, Wei-dong
Publicado 2016